Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-10

Clinical Trial Update: Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial assessing bromocriptine-QR therapy effects on sympathetic tone and vascular biology in subjects with diabetic autonomic neuropathy; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bromocriptine-QR (bromocriptine QR)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Diabetic Autonomic Neuropathy | Phase 4 | Status: COMPLETED | Results posted: 2021-12-10